🩺 Pre-Anaesthetic Check-up (PAC)

ASA Physical Status ASA Fasting 2023 ACC/AHA 2024 RCRI NICE NG45
Assess Β· Optimise Β· Plan ASA-PS Β· Airway Β· METs Fasting Β· Meds Β· Consent ASA Physical Status 2020 Β· ASA Fasting Guidelines 2023 (incl. GLP-1) Β· ACC/AHA Perioperative Guideline 2024 Β· NICE NG45 Β· Miller / Barash / Morgan & Mikhail / Stoelting 2022
πŸ“… Last reviewed July 2026 Β· Next review January 2027 Β· Compiled by Dr. Anmol Srivastava Anaesthesia, Emergency Medicine & Critical Care Medicine Β· Reviewed by Dr. Tanya Chawla Anaesthesia & Critical Care
πŸ“˜ 1 Β· Miller's Anesthesia, 9th Ed β€” Preoperative Evaluation

Why We Do It & the ASA Physical Status

"The purpose of the preoperative evaluation is not simply to 'clear' a patient for surgery. It is to characterise the patient's medical condition, estimate perioperative risk, optimise that condition where time allows, formulate an anaesthetic plan, and β€” through information and rapport β€” reduce the patient's anxiety. A good preoperative visit is the single most cost-effective intervention the anaesthetist makes: it prevents cancellations, avoids unnecessary tests, and turns surprises in theatre into decisions made in the clinic."

Miller's Anesthesia, 9th Ed. Preoperative Evaluation. Elsevier; 2020.

The PAC answers three questions

  • Is the patient in the best achievable condition for this surgery?
  • Is there anything that can be optimised in the time available? (and is the risk of delay worth the gain)
  • What is the safest anaesthetic plan β€” technique, airway, monitoring, post-op disposition (ward / HDU / ICU)?
πŸ“˜ ASA Physical Status Classification (ASA-PS)
ASA IA normal healthy patient (non-smoker, minimal alcohol). ASA IIMild systemic disease, no functional limitation β€” controlled HTN/DM, current smoker, pregnancy, obesity (BMI 30–40). ASA IIISevere systemic disease, functional limitation β€” poorly controlled DM/HTN, COPD, morbid obesity (BMI β‰₯40), stable angina, ESRD on dialysis, MI/CVA/stent >3 months ago. ASA IVSevere systemic disease that is a constant threat to life β€” recent (<3 months) MI/CVA/stent, ongoing ischaemia, severe valve disease, sepsis, EF <30%. ASA VMoribund; not expected to survive without the operation (ruptured AAA, massive trauma, ICH with mass effect). ASA VIBrain-dead; organs being removed for donation.

Add "E" for emergency surgery (e.g. ASA III E). ASA-PS predicts perioperative morbidity/mortality but is subjective and does not account for surgery type, age or airway β€” it is a communication shorthand, not a full risk score.

πŸ’ͺ Functional capacity is the cheapest risk test you have

Ask what the patient can actually do. Climbing two flights of stairs or brisk walking uphill β‰ˆ β‰₯4 METs and predicts they will tolerate most surgery. Poor (<4 METs) or indeterminate capacity in a patient facing intermediate/high-risk surgery is what should trigger further cardiac thought β€” not a resting ECG in an asymptomatic person.

Metabolic equivalents (METs) β€” grading functional capacity

1 MET = 3.5 mL Oβ‚‚/kg/min (resting oxygen uptake). 4 METs is the clinical threshold for proceeding without further cardiac testing.

CapacityCan the patient…
1 METLook after themselves β€” eat, dress, use the toilet; walk indoors around the house
2–3 METsWalk a block or two on level ground (3–5 km/h)
4 METs β—„ thresholdClimb a flight of stairs / walk up a hill; do light housework (dusting, washing dishes)
4–10 METsModerate work (scrubbing floors, moving furniture); golf, bowling, doubles tennis
>10 METsStrenuous sport β€” swimming, singles tennis, football
πŸ“ Duke Activity Status Index (DASI) β€” objective alternative

A 12-item self-administered questionnaire of daily activities (each carries a weight, e.g. self-care 2.75, climbing stairs 5.5, running 8, strenuous sport 7.5). It removes the subjectivity of "how many stairs" and estimates METs directly:

Estimated METs = (0.43 Γ— DASI score + 9.6) Γ· 3.5

NYHA functional class (heart-failure patients)

ClassLimitation
INo limitation β€” ordinary activity causes no symptoms
IISlight limitation β€” comfortable at rest; ordinary activity β†’ fatigue/dyspnoea/palpitations
IIIMarked limitation β€” comfortable at rest; less-than-ordinary activity β†’ symptoms
IVSymptoms at rest; any activity increases discomfort
πŸ“— 2 Β· Barash & Morgan/Mikhail β€” History, Examination & the Airway

The Focused History, Examination & Airway Assessment

"No investigation replaces a careful history and a look at the airway. The airway examination in particular is the one part of the preoperative assessment that only the anaesthetist can do and that no consultant referral will provide. A history of a previous difficult intubation is the strongest single predictor of a difficult airway β€” ask for it, and read the old anaesthetic chart."

Barash β€” Clinical Anesthesia, 9th Ed; Morgan & Mikhail's Clinical Anesthesiology, 6th Ed.

Focused history β€” what actually changes the plan

  • Presenting surgical problem + urgency (elective / urgent / emergency, and full-stomach status).
  • Comorbidities β€” cardiac (angina, MI, failure, valves, CIED), respiratory (asthma/COPD, OSA), diabetes, renal, hepatic, neuro (epilepsy, stroke, raised ICP), thyroid.
  • Previous anaesthesia β€” difficult airway, PONV, awareness, prolonged block; family history of malignant hyperthermia or suxamethonium apnoea (pseudocholinesterase deficiency).
  • Drugs & allergies β€” anticoagulants/antiplatelets, insulin, steroids, GLP-1 agonists, SGLT2 inhibitors; latex/antibiotic/anaesthetic allergy (and what actually happened).
  • Social β€” smoking, alcohol/recreational drugs, exercise tolerance (METs), pregnancy/LMP.
  • Fasting status and whether an interpreter or attendant is needed.
🫁 Airway assessment β€” the bedside bundle
LookFacial trauma, beard, receding chin, buck teeth, short/thick neck, goitre, scars
Mallampati (I–IV) β€” mouth open, tongue out, no phonation; III–IV predicts difficulty
Mouth opening β‰₯3 cm (2–3 fingers) Β· Thyromental distance >6.5 cm Β· Upper-lip-bite test
Neck movement β€” atlanto-occipital extension; dentition β€” loose/capped/crowns, edentulous
SynthesiseDifficult intubation (LEMON) Β· Difficult mask ventilation (MOANS) Β· Difficult SGA / front-of-neck access
🧠 The airway mnemonics worth remembering
  • LEMON (difficult laryngoscopy/intubation): Look externally Β· Evaluate 3-3-2 (3 fingers mouth opening, 3 fingers hyoid–chin, 2 fingers floor-of-mouth–thyroid) Β· Mallampati Β· Obstruction/Obesity Β· Neck mobility.
  • MOANS (difficult mask ventilation): Mask seal (beard) Β· Obesity/Obstruction Β· Age >55 Β· No teeth Β· Stiff lungs/Snoring (OSA).
  • Predictors of difficult SGA β€” RODS; difficult cricothyrotomy β€” SHORT (Surgery/Scar, Haematoma, Obesity, Radiation, Tumour).

Bedside airway tests β€” thresholds & significance

No single test predicts a difficult airway reliably β€” combine several. The figures below are the ones asked in vivas.

TestHow to do itReassuringConcerning β†’ difficult
Modified MallampatiSitting, head neutral, mouth wide open, tongue maximally out, no phonationClass I (soft palate, fauces, uvula, pillars) / Class II (uvula tip hidden)Class III (only soft palate) / IV (only hard palate)
Inter-incisor gap (mouth opening)Maximal mouth opening between incisors>5 cm / admits 3 fingers<3 cm β†’ difficult laryngoscopy; <2 cm β†’ difficult LMA
Thyromental distance (TMD)Thyroid notch β†’ tip of chin, neck fully extended>6.5 cm6–6.5 cm difficult but possible; <6 cm may be impossible
Hyomental distanceHyoid bone β†’ mentum>6 cm (Grade I)4–6 cm (II); <4 cm (III) β€” impossible laryngoscopy/intubation
Upper-lip-bite testAsk patient to bite the upper lip with the lower incisorsClass I β€” bite above the vermilion lineClass II (below vermilion); Class III β€” cannot reach lip
Mandibular protrusion (ULBT variant)Advance lower incisors in front of the upper incisorsClass A β€” lower teeth protrude beyond upperClass B / C β†’ difficult laryngoscopy
Neck / atlanto-occipital movementChin-to-chest (flexion) & look at the ceiling without raising brows (extension)Full flexion + extensionβ‰₯β…” loss of AO extension β†’ difficult rigid laryngoscopy
3-3-2 rulePatient's own fingers3 (mouth opening) Β· 3 (hyoid–chin) Β· 2 (thyroid notch–floor of mouth)Any value smaller than above

Systemic examination

  • Vitals & general β€” BP both arms if relevant, SpOβ‚‚, weight/BMI, pallor, cyanosis, oedema, hydration.
  • CVS β€” heart sounds, murmurs, JVP, peripheral pulses, signs of failure.
  • RS β€” air entry, added sounds, wheeze; SpOβ‚‚ on air.
  • Spine & back β€” landmarks, deformity, local sepsis if regional/neuraxial planned; peripheral neurology if a block is planned.
  • IV access β€” anticipate difficulty; site for lines.
πŸ“™ 3 Β· Stoelting's Anesthesia & Co-Existing Disease, 8th Ed

Co-Existing Disease β€” System by System

"The goal of the preoperative visit in the patient with co-existing disease is to ensure the disease is treated as well as it reasonably can be before an elective operation, and to decide which chronic therapies are continued, modified, or stopped. Cancelling a case rarely improves outcome unless the delay is used to make a specific, achievable change β€” a controlled blood sugar, a treated infection, a rate-controlled AF, an optimised inhaler regimen."

Stoelting's Anesthesia and Co-Existing Disease, 8th Ed. Elsevier; 2022.
❀️ Cardiovascular
  • IHD / stents: liaise with cardiology before any elective surgery and do not stop dual antiplatelet therapy without their input β€” balance the risk of stent thrombosis against surgical bleeding.
  • Hypertension: proceed if BP <180/110; very high pressures on the day are usually anxiety/white-coat β€” continue most agents (see Β§5).
  • Heart failure: decompensated failure is high-risk β€” echo and optimise first. Know the CIED (pacemaker/ICD) type and the reprogramming/magnet plan for diathermy.
🫁 Respiratory
  • Asthma / COPD: operate when optimised and infection-free; continue inhalers; a course of steroids/nebulisers for an exacerbation is worth the delay.
  • Smoking cessation: helps most when stopped >4–8 weeks before surgery; even 24–48 h lowers carboxyhaemoglobin and improves oxygen delivery.
  • OSA: screen with the STOP-BANG questionnaire (below); a high score means plan opioid-sparing analgesia and enhanced post-operative monitoring.
STOP-BANG questionnaire for OSA β€” score 1 point for each "yes"
S β€” SnoringDo you snore loudly (louder than talking, or audible through a closed door)?
T β€” TirednessDo you often feel tired, fatigued or sleepy during the daytime?
O β€” Observed apnoeaHas anyone observed you stop breathing, choke or gasp during sleep?
P β€” PressureDo you have, or are you being treated for, high blood pressure?
B β€” BMIIs your BMI greater than 35 kg/mΒ²?
A β€” AgeAre you older than 50 years?
N β€” NeckIs your neck circumference greater than 40 cm (β‰ˆ16 inches)?
G β€” GenderAre you male?

Interpretation: 0–2 = low risk Β· 3–4 = intermediate risk Β· β‰₯5 = high risk of moderate-to-severe obstructive sleep apnoea.

🩸 Endocrine
  • Diabetes: assess control (HbA1c), aim for a capillary glucose of ~6–10 mmol/L on the day, and place the patient first on the list; manage agents per Β§5.
  • Thyroid: render the patient euthyroid before elective surgery; continue anti-thyroid or replacement therapy on the day.
  • Steroids / adrenal: continue chronic corticosteroids and give a perioperative stress dose for significant surgery (Β§5).
πŸ§ͺ Renal
  • Know the eGFR and dialysis schedule (dialyse the day before, not immediately before surgery); correct electrolytes β€” especially potassium.
  • Adjust the choice and dose of renally-excreted drugs and avoid nephrotoxins.
  • Anaemia: investigate and treat (iron Β± erythropoietin) before elective surgery β€” a modifiable, independent risk factor that reduces transfusion.
πŸ«€ Hepatic
  • Assess severity (Child–Pugh / MELD) and correct any coagulopathy; anticipate altered drug handling.
  • Identify and manage the complications β€” ascites, encephalopathy, varices and hypoalbuminaemia β€” before an elective case.
πŸ“‹ 4 Β· Guidelines β€” Fasting Β· Cardiac Risk Β· Investigations

Evidence-Based Guidelines

Pre-operative fasting ASA 2023
Minimum fasting for elective procedures under sedation/GA/regional:
β€’ Clear fluids β€” 2 hours (water, black tea/coffee, pulp-free juice, carbohydrate drinks; encourage clears up to 2h)
β€’ Breast milk β€” 4 hours
β€’ Infant formula / light meal (toast) β€” 6 hours
β€’ Fatty/fried food, meat, full meal β€” 8 hours
GLP-1 receptor agonists (semaglutide etc.): delay gastric emptying β€” the ASA 2023 consensus advises holding the dose on the day of surgery (daily preparations) or the week of surgery (weekly preparations); if not held or GI symptoms are present, treat as a full stomach (consider gastric ultrasound / RSI).
Pharmacological aspiration prophylaxis for at-risk patients
Not routine β€” reserve for the higher-aspiration-risk patient (delayed gastric emptying, GORD, hiatus hernia, diabetes, obesity, pregnancy/labour, emergency/full stomach, difficult airway):
ClassExampleAction
Hβ‚‚-receptor antagonistRanitidine, famotidine↓ gastric acid secretion β†’ lower volume & higher pH (needs time to work)
Proton-pump inhibitorOmeprazole, pantoprazoleSuppress acid by blocking the parietal-cell proton pump
Non-particulate antacidSodium citrate 0.3 MImmediate neutralisation of existing acid β€” first choice in obstetrics
ProkineticMetoclopramide (dopamine antagonist)Speeds gastric emptying & raises lower-oesophageal-sphincter tone
Revised Cardiac Risk Index (RCRI) Lee index
The RCRI predicts the risk of a major adverse cardiac event (MACE) β€” defined as myocardial infarction, cardiac arrest or death (some versions also include complete heart block and pulmonary oedema) β€” after non-cardiac surgery. Score 1 point for each factor present:
RCRI predictor β€” 1 point each
High-risk surgery β€” intraperitoneal, intrathoracic or suprainguinal vascular
Ischaemic heart disease
History of congestive heart failure
History of cerebrovascular disease (stroke / TIA)
Insulin-treated diabetes mellitus
Serum creatinine >177 Β΅mol/L (2 mg/dL)
RCRI scoreEstimated risk of MACE
0~0.4%
1~0.9%
2~6.6%  (elevated)
β‰₯3~11%
Stepwise testing β€” not reflex ACC/AHA 2024
For elevated-risk patients with poor or unknown functional capacity (<4 METs) facing intermediate/high-risk surgery, consider biomarkers (BNP/NT-proBNP) and only pursue further testing (stress imaging) if it will change management. Do not order a routine resting ECG or echo in asymptomatic patients for low-risk surgery. Continue statins and established beta-blockers; do not start beta-blockers on the day of surgery.
Surgical risk (30-day MACE)Examples
High  (>5%)Emergency major operations (esp. in the elderly); aortic & major vascular; peripheral vascular; anticipated prolonged surgery with large fluid shifts and/or blood loss
Intermediate  (<5%)Carotid endarterectomy; head & neck; intraperitoneal & intrathoracic; orthopaedic; prostate
Low  (<1%)Endoscopic procedures; superficial procedures; cataract; breast; ambulatory / day-case surgery
Investigations β€” as per institutional protocol directed, not routine
Follow your institutional protocol. Where none applies, direct tests by ASA grade Γ— surgical grade (NICE NG45 principle), not by a blanket routine battery:
β€’ FBC β€” if ASA III/IV, or major surgery, or symptoms of anaemia.
β€’ U&E / renal β€” if at risk of AKI, on relevant drugs (ACEi/diuretic), ASA III/IV, or major surgery.
β€’ ECG β€” cardiovascular/renal disease, ASA III+, or major surgery (not routine by age alone).
β€’ HbA1c β€” known/suspected diabetes; Ξ²-hCG β€” where pregnancy is possible (ask & document); sickle test where relevant; group & save/crossmatch per expected blood loss.
Coagulation only for liver disease, anticoagulants or bleeding history β€” not "routine".
Consent & the plan
Take informed consent for the anaesthetic technique and its material risks (Montgomery standard β€” what this patient would want to know), including common events (sore throat, PONV, shivering) and serious ones relevant to the case (dental damage, awareness, nerve injury, aspiration). Agree the plan: technique, airway device, lines/monitoring, analgesia, antiemetic and VTE prophylaxis, and post-op destination. Premedication and anxiolysis where indicated.
πŸ’Š 5 Β· Perioperative Medication Management

What to Continue, Modify or Stop

Drug / ClassPeri-op instructionWhy
Beta-blockersContinue (incl. morning of surgery)Abrupt withdrawal β†’ rebound ischaemia/tachycardia; don't start de novo on the day (POISE β€” stroke/hypotension)
StatinsContinuePlaque stabilisation; continued through the perioperative period
ACE inhibitors / ARBsConsider omitting morning dose (esp. if taken for HTN)Refractory intra-op hypotension; continue if for heart failure β€” individualise
AspirinContinue for secondary prevention/stents (surgeon-dependent); stop 5–7 d only if bleeding risk > thromboticBalance stent thrombosis vs surgical bleeding
Clopidogrel / P2Y12Stop 5–7 days pre-op β€” only after cardiology input for stentsBleeding vs stent thrombosis; timing driven by stent age
WarfarinStop 5 days pre-op, check INR <1.5; bridge with LMWH only if high thrombotic riskMost patients (incl. AF) do not need bridging (BRIDGE trial)
DOACsStop 24–48 h (up to 72 h if high bleed risk / renal impairment); no routine bridgingPredictable pharmacokinetics; timing by drug + eGFR + bleeding risk
MetforminContinue up to day of surgery in most; omit on the day for major surgery / contrast / renal impairmentSmall lactic-acidosis risk only with AKI/hypoperfusion
SGLT2 inhibitors (β€”gliflozins)Stop 3–4 days before surgeryEuglycaemic diabetic ketoacidosis risk
GLP-1 agonists (β€”glutides)Hold day-of (daily) / week-of (weekly); full-stomach precautionsDelayed gastric emptying β†’ aspiration (ASA 2023)
InsulinLong-acting: 60–80% of usual dose the night before/morning; withhold short-acting while fasting; VRIII for major/poorly controlledAvoid hypoglycaemia while starved; maintain control
Corticosteroids (chronic)Continue + peri-op stress dose for significant surgerySuppressed HPA axis β†’ adrenal crisis
DiureticsOmit on the day of surgery β€” except a thiazide taken for hypertension (continue)Hypovolaemia/hypotension & electrolyte shifts on induction
NSAIDsStop 48 h before surgery (COX-2 selective may be continued unless bone-healing concern)Platelet effect / bleeding, renal impairment
Sildenafil & PDE-5 inhibitorsStop 24 h before surgeryRefractory hypotension with anaesthetic vasodilators
OCP / HRTConsider stopping 4 weeks before major/lower-limb surgery (VTE risk) β€” balance vs pregnancy riskOestrogen is prothrombotic
Herbal / OTCStop the "G"s ~1–2 weeks before (Garlic, Ginkgo, Ginseng, etc.)Bleeding, drug interactions, sedation
βœ… Continue on the morning: the "don't stop" list

Beta-blockers, statins, most antihypertensives (except ACEi/ARB β€” individualise), inhalers, antiepileptics, anti-parkinsonian, thyroid, immunosuppressants, most psychiatric drugs, and chronic steroids. Give with a sip of water. When in doubt, the harm is usually in stopping chronic therapy, not continuing it.

πŸ—Ί 6 Β· Clinical Flowchart

The PAC Workflow

1

History & records

  • Surgical problem + urgency + fasting/full-stomach status
  • Comorbidities, previous anaesthesia, family h/o (MH, scoline apnoea), drugs, allergies
  • Functional capacity (METs), smoking/alcohol, pregnancy; read the old anaesthetic chart
2

Examination β€” airway first

  • Mallampati, mouth opening, TMD, 3-3-2, neck movement, dentition (LEMON/MOANS)
  • CVS, RS, spine/back if regional planned, IV access
  • Assign ASA physical status (Β± E)
3

Targeted investigations

  • Order by ASA grade Γ— surgical grade (NICE NG45) β€” not a routine battery
  • Cardiac work-up only if it will change management (poor METs + higher-risk surgery)
4

Optimise & instruct

  • Optimise comorbidities where time allows (glucose, inhalers, rate control, anaemia)
  • Medication plan (continue/stop/bridge β€” Β§5); fasting instructions (ASA 2023)
  • Only cancel if delay buys a specific, achievable improvement
5

Plan, consent & premedicate

  • Technique, airway device, lines/monitoring, analgesia, PONV & VTE prophylaxis
  • Post-op destination (ward / HDU / ICU); informed consent (Montgomery)
  • Anxiolysis/premedication and aspiration prophylaxis where indicated
⚠️ 7 · Common Mistakes

Common Mistakes in the PAC

❌ Mistake 1 β€” Ordering a "routine" panel of tests

Age-based or blanket investigations in a well ASA I patient for minor surgery add cost, delay and false-positive chases without improving outcome. Test by comorbidity and surgical grade (NICE NG45).

❌ Mistake 2 β€” Skipping or under-documenting the airway exam

The airway assessment is the one thing only the anaesthetist can do. A previous difficult intubation is the strongest predictor β€” always ask and read the old chart. Document Mallampati, mouth opening, TMD, neck movement and dentition.

❌ Mistake 3 β€” Stopping chronic drugs that should continue

Beta-blockers, statins, inhalers, antiepileptics and steroids should continue. Rebound ischaemia (beta-blocker withdrawal) and adrenal crisis (steroid omission) are avoidable harms.

❌ Mistake 4 β€” Missing the new high-risk drugs: GLP-1 agonists & SGLT2 inhibitors

GLP-1 agonists delay gastric emptying (aspiration risk β€” hold and treat as full stomach if not held). SGLT2 inhibitors cause euglycaemic DKA β€” stop 3–4 days before. Both are now very common and easy to overlook.

❌ Mistake 5 β€” Reflex "NPO after midnight"

Prolonged starvation causes dehydration, hypoglycaemia and misery with no benefit. Encourage clear fluids up to 2 hours before surgery (ASA 2023).

❌ Mistake 6 β€” Cancelling for a high clinic BP or an incidental abnormality

Isolated white-coat hypertension <180/110 is not a reason to cancel. Cancel only when the delay will be used to achieve a specific, worthwhile optimisation.

❌ Mistake 7 β€” Bridging every anticoagulated patient

Most patients on warfarin (including AF) do not need LMWH bridging (BRIDGE trial β€” more bleeding, no thrombotic benefit). Reserve bridging for genuinely high thrombotic risk (mechanical mitral valve, recent VTE/stroke).

πŸŽ“ 8 Β· Exam Pearls β€” DrNB / MD / FCPS / EDAIC

Exam Pearls

Q: What are the objectives of the pre-anaesthetic check-up?
Assess and characterise the patient's condition, estimate perioperative risk, optimise co-existing disease, formulate the anaesthetic plan, obtain informed consent, and reduce anxiety β€” while avoiding unnecessary tests and cancellations.

Q: Define the ASA physical status classes.
I normal healthy; II mild systemic disease; III severe systemic disease (functional limitation); IV severe disease that is a constant threat to life; V moribund, not expected to survive without surgery; VI brain-dead organ donor. Add "E" for emergency. It is subjective and ignores surgery type, age and airway.

Q: State the ASA 2023 fasting times.
Clear fluids 2 h, breast milk 4 h, formula/light meal 6 h, fatty/fried/full meal 8 h. GLP-1 agonists: hold on the day (daily) or the week (weekly) and treat as full stomach if not held.

Q: What is the Revised Cardiac Risk Index?
Six equally-weighted predictors: high-risk surgery, ischaemic heart disease, heart failure, cerebrovascular disease, insulin-treated diabetes, creatinine >2 mg/dL. Increasing points β†’ increasing risk of major cardiac events.

Q: How do you assess the airway pre-operatively?
History of difficulty + LEMON: Look externally, Evaluate 3-3-2, Mallampati, Obstruction/Obesity, Neck mobility; plus mouth opening, thyromental distance, dentition and upper-lip-bite test. MOANS predicts difficult mask ventilation.

Q: How much does functional capacity matter, and how is it measured?
Greatly β€” β‰₯4 METs (two flights of stairs, brisk uphill walk) predicts tolerance of most surgery. Poor/unknown capacity before higher-risk surgery is what triggers further cardiac assessment (ACC/AHA 2024), not routine testing.

Q: Which drugs do you stop, and when, before surgery?
SGLT2 inhibitors 3–4 days; clopidogrel 5–7 days; warfarin 5 days (INR <1.5); DOACs 24–72 h by drug/eGFR/bleed risk; GLP-1 agonists on the day/week; the herbal "G"s 1–2 weeks. Continue beta-blockers, statins, inhalers, antiepileptics and steroids.

Q: STOP-BANG β€” what is it?
An OSA screen: Snoring, Tiredness, Observed apnoea, high Pressure (BP), BMI >35, Age >50, Neck >40 cm, male Gender. β‰₯3 = intermediate–high risk β†’ opioid-sparing plan and enhanced post-op monitoring.

πŸ“š 9 Β· References

References

  1. Gropper MA, et al. (eds). Miller's Anesthesia, 9th Edition. Preoperative Evaluation. Philadelphia, PA: Elsevier; 2020.
  2. Barash PG, Cullen BF, Stoelting RK, et al. (eds). Clinical Anesthesia, 9th Edition. Preoperative Assessment & the Airway. Wolters Kluwer; 2023.
  3. Butterworth JF, Mackey DC, Wasnick JD. Morgan & Mikhail's Clinical Anesthesiology, 6th Edition. Preoperative Evaluation & Airway Management. McGraw-Hill; 2018.
  4. Hines RL, Marschall KE (eds). Stoelting's Anesthesia and Co-Existing Disease, 8th Edition. Elsevier; 2022.
  5. American Society of Anesthesiologists. ASA Physical Status Classification System (last approved/amended 2020).
  6. ASA Task Force on Preoperative Fasting. Practice Guidelines for Preoperative Fasting β€” 2023 update, and 2023 consensus on GLP-1 receptor agonists. Anesthesiology.
  7. Thompson A, et al. (ACC/AHA). 2024 Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery. Circulation / J Am Coll Cardiol. 2024.
  8. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of the Revised Cardiac Risk Index (RCRI). Circulation. 1999;100:1043–1049.
  9. National Institute for Health and Care Excellence. Routine preoperative tests for elective surgery (NG45). NICE; 2016.
  10. Douketis JD, Spyropoulos AC, Kaatz S, et al. (BRIDGE). Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. N Engl J Med. 2015;373:823–833.
  11. POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial). Lancet. 2008;371:1839–1847.